Update on Antiviral Treatment of Adenoviral Ocular Infections

American Journal of Ophthalmology

Volumn 146, Issue 5, 2008, Pages 635-637

  Romanowski, Eric G ^a   Gordon, Y Jerold ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4,5 DIHYDROXY 3 HYDROXYMETHYL 2 CYCLOPENTEN 1 YL)CYTOSINE; ACICLOVIR; ANTIVIRUS AGENT; CIDOFOVIR; CTC 96; DIDANOSINE; DIGOXIN; DOXOVIR; FUROSEMIDE; IMMUNOGLOBULIN G; N CHLOROTAURINE; TAURINE DERIVATIVE; TRIFLURIDINE; UNCLASSIFIED DRUG; ZALCITABINE;

ADENOVIRUS; ANTIVIRAL ACTIVITY; CLINICAL TRIAL; DRUG EFFECT; DRUG RESEARCH; DRUG SAFETY; EDITORIAL; HUMAN; HYPOTENSION; PANCREATITIS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; VIRAL CONJUNCTIVITIS; VIRAL EYE INFECTION;

ADENOVIRIDAE INFECTIONS; ANIMALS; ANTIVIRAL AGENTS; CYTIDINE; EYE INFECTIONS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; ZALCITABINE;

EID: 54849404158     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2008.07.030     Document Type: Editorial

References (18)

1. Murrah W.F. Epidemic keratoconjunctivitis. Ann Ophthalmol 20 (1988) 36-38
2. Uchio E., Fuchigami A., Kadonosono K., et al. Anti-adenoviral effect of anti-HIV agents in vitro in serotypes inducing keratoconjunctivitis. Graefes Arch Clin Exp Ophthalmol 245 (2007) 1319-1325
3. Gordon J.S., Aoki K., and Kinchington P.R. Adenovirus keratoconjunctivitis. In: Pepose J.S., Holland G.N., and Wilhelmus K.R. (Eds). Ocular Infection & Immunity (1996), Mosby, St Louis, Missouri 877-894
4. American Academy of Ophthalmology. Preferred Practice Pattern, Adenoviral Conjunctivitis. http://one.aao.org/CE/PracticeGuidelines/PPP Accessed: May 20, 2008
5. Romanowski E.G., Gordon Y.J., Araullo-Cruz T., Yates K.A., and Kinchington P.R. The antiviral resistance and replication of cidofovir-resistant adenovirus variants in the New Zealand white rabbit ocular model. Invest Ophthalmol Vis Sci 42 (2001) 1812-1815
6. Hillenkamp J., Reinhard T., Ross R.S., et al. The effects of cidofovir 1% with and without cyclosporin A 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study. Ophthalmology 109 (2002) 845-850
7. Romanowski E.G., Yates K.A., Teuchner B., Nagl M., Irschick E.U., and Gordon Y.J. N-chlorotaurine is an effective antiviral agent against adenovirus in vitro and in the Ad5/NZW rabbit ocular model. Invest Ophthalmol Vis Sci 47 (2006) 2021-2026
8. Nagl M., and Gottardi W. Enhancement of the bactericidal efficacy of N-chlorotaurine by inflammation samples and selected N-H compounds. Hyg Med 21 (1996) 597-605
9. Nagl M., Miller B., Daxecker F., Ulmer H., and Gottardi W. Tolerance of N-chlorotaurine, an endogenous antimicrobial agent, in the rabbit and human eye-a phase I clinical study. J Ocular Pharmacol Ther 14 (1998) 283-290
10. Nagl M., Teuchner B., Pöttinger E., Ulmer H., and Gottardi W. Tolerance of N-chlorotaurine, a new antimicrobial agent, in infectious conjunctivitis-a phase II pilot study. Ophthalmologica 214 (2000) 111-114
11. Teuchner B., Nagl M., Schidlbauer A., et al. Tolerability and efficacy of N-chlorotaurine in epidemic keratoconjunctivitis-a double-blind, randomized, phase-2 clinical trial. J Ocular Pharmacol Ther 21 (2005) 157-165
12. Epstein S.P., Pashinsky Y.Y., Gershon D., et al. Efficacy of topical cobalt chelate CTC-96 against adenovirus in a cell culture model and against adenovirus keratoconjunctivitis in a rabbit model. BMC Ophthalmology 6 (2006) 22
13. Asbell P.A., Epstein S.P., Wallace J.A., Epstein D., Stewart C.C., and Burger R.M. Efficacy of cobalt chelates in the rabbit eye model for epithelial herpetic keratitis. Cornea 17 (1998) 550-557
14. Hartley C., Hartley M., Pardoe I., and Knight A. Ionic contra-viral therapy (ICVT); a new approach to the treatment of DNA virus infections. Arch Virol 151 (2006) 2495-2501
15. Nwanegbo E.C., Romanowski E.G., Gordon Y.J., and Gambotto A. Efficacy of topical immunoglobulins (IG) against experimental adenoviral ocular infection. Invest Ophthalmol Vis Sci 48 (2007) 4171-4176
16. Van der Vliet P.C., and Kwant M.M. Role of DNA polymerase γ in adenovirus DNA replication. Mechanism of inhibition by 2,′2′-dideoxynucleoside 5′-triphosphates. Biochemistry 20 (1981) 2628-2632
17. De Clercq E., Murase J., and Marquez V.E. Broad-spectrum antiviral and cytocidal activity of cyclopentenylcytosine, a carbocyclic nucleoside targeted at CTP synthetase. Biochem Pharmacol 41 (1991) 1821-1829
18. Marquez V.E., Lim M.I., Treanor S.P., et al. Cyclopentenylcytosine. A carbocyclic nucleoside with antitumor and antiviral properties. J Med Chem 31 (1988) 1687-1694